Biotech entrepreneur Sam Waksal has been accused of "reckless conduct," including using a veterinary medicine on a severely ...

According to a new report by the US National Security Commission on Emerging Biotechnology, China’s systematic state-driven ...

Sweden's Biotage said on Tuesday that KKR had made a cash offer for the Swedish biotechnology firm, valuing it at around 11.6 ...

Gilead Sciences said a combination of its cancer drug Trodelvy and Merck’s Keytruda delayed the growth of tumors in women ...

Hosted at nonprofit incubator and accelerator Winston Starts, The Founders’ Journey focused on venture-backed biotechnology ...

Eupraxia Pharmaceuticals Inc.’s EPRX share price has surged by 5.46%, which has investors questioning if this is right time ...

Shares in private equity giant KKR (KKR) were higher today after it made a $1.2 billion takeover offer for Swedish biotechnology company ...

Press Release GridX, Latin America's largest biotechnology investment fund and company builder, is set to begin its international Roadshow featuring 21 innovative startups across three strategic U.S.

Addressing ongoing public skepticism about genetically modified organisms (GMOs), Dr. Salako firmly debunked myths linking ...

Following biotechnology company 23andMe's filing for bankruptcy, losing its CEO, and trying to find a buyer last month, the ...

Vir Biotechnology, Inc.’s VIR share price has surged by 5.82%, which has investors questioning if this is right time to sell.

Once completed, it will specialize in science, technology, engineering, and mathematics or STEM, and open in fall 2027.